36 results on '"Ivanyi P"'
Search Results
2. Onkologische Aspekte der Behandlung pathologischer Frakturen.
3. Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?
4. Revolution in der Systemtherapie des metastasierten Nierenzellkarzinoms.
5. Systemtherapie des Nierenzellkarzinoms.
6. PREPARE: Phase-III-Studie zur proaktiven Therapiebegleitung (Coaching) in Bezug auf die Patienteneinschätzung der Lebensqualität unter Behandlung eines fortgeschrittenen oder metastasierten Nierenzellkarzinoms mit Checkpoint-Inhibitoren plus Axitinib oder Sunitinib-Monotherapie
7. c-Met Onkogen bei Nierenzellkarzinomen.
8. Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC).
9. Does the onset of bone metastasis in sunitinib-treated renal cell carcinoma patients impact the overall survival?
10. Die Systemische Behandlung des metastasierten Nierenzellkarzinoms -- Zurück in die Zukunft?
11. Tumorbedingte pathologische Frakturen.
12. Response of renal lesions during systemic treatment with sunitinib in patients with metastatic renal cell carcinoma: a single center experience with 14 patients.
13. Nierenzellkarzinom.
14. Therapie des Nierenzellkarzinoms.
15. PARTITIONING OF TALL BUILDINGS USING BUBBLE GRAPH REPRESENTATION.
16. SPECIFICITY OF ANTI-H-2 CLASS I ANTIBODIES INDUCED BY SYNGENEIC IMMUNIZATION WITH SENDAI VIRUS-TREATED CELLS IS REGULATED BY THE MOUSE MHC AND VIRAL ANTIGENS. NO EVIDENCE FOR MHC-RESTRICTED VIRUS- SPECIFIC ANTIBODIES.
17. ANTI-MHC IMMUNITY DETECTED PRIOR TO INTENTIONAL ALLOIMMUNIZATION.
18. UNEXPECTED LYMPHO-CYTOTOXIC REACTIONS OF ANTI-H-2 SERA ON NORMAL LYMPH-NODE CELLS: ARE THEY DUE TO ALTERED H-2 STRUCTURES OR ANTI-VIRAL ANTIBODIES?
19. HLA expression and function in single and double HLA-B27-transgenic mice.
20. Different linkage disequilibria of HLA-B27 subtypes and HLA-C locus alleles.
21. CROSS-REACTIVITY AMONG THE PRODUCTS OF THREE NONALLELIC H-2 LOCI, H-2Ld, H-2Dq, AND H-2Kk.
22. Absence of autoantibodies to peptides shared by HLA-B27.5 and Klebsiella pneumoniae nitrogenase in serum samples from HLA-B27 positive patients with ankylosing spondylitis and Reiter's syndrome.
23. Distribution of HLA-B27 subtypes in patients with ankylosing spondylitis: the disease is associated with a common determinant of the various B27 molecules.
24. Immunogenetics of the spondyloarthropathies.
25. HLA Class-I-transgenic Mice as Model System to Study MHC-restricted Antigen Recognition in Man.
26. Effect of a Tyr-to-His Point-mutation at Position 59 in the Alpha-1 Helix of the HLA-B27 Class-I Molecule on Allospecific and Virus-specific Cytotoxic T-lymphocyte Recognition.
27. Dysfunction of HLA-B27.
28. Natural H-2-specific antibodies in sera of aged mice.
29. TISSUE ALLOANTIGENS PRESENT IN HUMAN LEUKOCYTES*.
30. Allo-Antigens and Antigenic Factors of Human Leukocytes: A Hypothesis.
31. Sexual dimorphism, but not testosterone itself, is responsible for ankylosing enthesitis of the ankle in B10.BR (H-2k) male mice.
32. Hysteresis in column systems.
33. Failure to Detect Cross-reacting Antibodies to HLA-B27.5 and Klebsiella pneumoniae Nitrogenase in Sera from Patients with Ankylosing Spondylitis and Reiter's Syndrome.
34. Full-scale tests on steel frames under cyclic loading.
35. B27-Transgenic Mice and Disease.
36. Prolonged survival of maternal skin grafts in newborn rabbits.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.